TXG
10X Genomics Inc
84.10$
+11.2%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +64.4% | +387.4% | +53.4% | +9.6% | +1.0% | -6.2% | -4.8% | +13.4% | |
| – | +56.0% | +352.6% | +61.0% | -3.5% | -15.1% | -6.1% | -2.0% | +17.1% | |
| – | +36.0% | +551.8% | +56.4% | -11.5% | -62.6% | +63.5% | -4.2% | +37.8% | |
| – | +36.0% | +551.8% | +56.4% | -11.5% | -26.8% | -9.6% | +1.2% | +33.0% | |
| – | +110.5% | +18.8% | +53.5% | +66.5% | +22.2% | +10.2% | -23.5% | -6.1% | |
| – | +77.1% | +78.2% | +96.2% | +100.2% | +36.1% | -9.7% | +12.8% | -32.2% | |
| – | +60.7% | +338.8% | +49.2% | +216.3% | +25.6% | – | – | – | |
| – | – | – | – | – | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | +0.0% | +5,488.5% | +13.6% | -10.0% | -27.3% | -5.7% | +297.7% | |
| – | +83.0% | -46.0% | +2.4% | +5.8% | +10.9% | +0.4% | -7.0% | +17.5% | |
| – | +46.2% | +94.8% | +87.4% | -6.6% | +18.7% | -2.9% | -7.5% | +30.5% | |
| – | -0.9% | +136.0% | -39.9% | -13.6% | +76.1% | +27.5% | -19.4% | +18.3% | |
| – | +61.5% | +48.2% | -63.9% | +268.5% | +24.5% | -27.1% | -18.0% | -1.4% | |
| – | +302.4% | -22.2% | – | – | – | – | – | – | |
| – | – | – | +75.9% | +10.6% | -1.4% | -8.0% | -4.2% | +12.1% | |
| – | – | – | – | – | – | – | – | – | |
| – | +15.6% | +483.8% | +29.4% | +9.1% | +3.2% | +2.9% | +2.8% | +3.6% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.